A citation-based method for searching scientific literature

Thomas B Silverman, Gilad J Kuperman, Alejandro Vanegas, Margaret Sin, Jill Dimond, Katherine D Crew, Rita Kukafka. AMIA Annu Symp Proc 2018
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.
Margaret I Liang, Deanna H Wong, Christine S Walsh, Robin Farias-Eisner, Joshua G Cohen. J Genet Couns 2018
10
33


Differences in BRCA counseling and testing practices based on ordering provider type.
Deborah Cragun, Lucia Camperlengo, Emily Robinson, Meghan Caldwell, Jongphil Kim, Catherine Phelan, Alvaro N Monteiro, Susan T Vadaparampil, Thomas A Sellers, Tuya Pal. Genet Med 2015
27
33

Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.
K D Graves, B N Peshkin, G Luta, W Tuong, M D Schwartz. Public Health Genomics 2011
41
33

Experiences of genetic counseling for BRCA1/2 among recently diagnosed breast cancer patients: a qualitative inquiry.
Susan T Vadaparampil, Gwendolyn Pickard Quinn, Jennifer Brzosowicz, Cheryl A Miree. J Psychosoc Oncol 2008
15
33

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
879
33

Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Maira Kentwell, Eryn Dow, Yoland Antill, C David Wrede, Orla McNally, Emily Higgs, Anne Hamilton, Sumitra Ananda, Geoffrey J Lindeman, Clare L Scott. Gynecol Oncol 2017
54
33


Systematic review of the empirical investigation of resources to support decision-making regarding BRCA1 and BRCA2 genetic testing in women with breast cancer.
Chloe Grimmett, Karen Pickett, Jonathan Shepherd, Karen Welch, Alejandra Recio-Saucedo, Elke Streit, Helen Seers, Anne Armstrong, Ramsey I Cutress, D Gareth Evans,[...]. Patient Educ Couns 2018
9
33

Ovarian cancer in BRCA mutation carriers: improved outcome after intraperitoneal (IP) cisplatin.
Maryann Kwa, Susan Edwards, Andrea Downey, Elsa Reich, Robert Wallach, John Curtin, Franco Muggia. Ann Surg Oncol 2014
18
33


Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.
Allison W Kurian, Kevin C Ward, Nadia Howlader, Dennis Deapen, Ann S Hamilton, Angela Mariotto, Daniel Miller, Lynne S Penberthy, Steven J Katz. J Clin Oncol 2019
90
33

Patterns and predictors of genetic referral among ovarian cancer patients at a National Cancer Institute-Comprehensive Cancer Center.
Adrianne R Mallen, Claire C Conley, Mary K Townsend, Ali Wells, Bernadette M Boac, Sarah Todd, Anjalika Gandhi, Michelle Kuznicki, Bianca M Augusto, McKenzie McIntyre,[...]. Clin Genet 2020
3
33

Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers.
Claudia Marchetti, Francesca De Felice, Innocenza Palaia, Giorgia Perniola, Angela Musella, Daniela Musio, Ludovico Muzii, Vincenzo Tombolini, Pierluigi Benedetti Panici. BMC Womens Health 2014
86
33

Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
Denise Uyar, Jamie Neary, Amy Monroe, Melodee Nugent, Pippa Simpson, Jennifer L Geurts. Gynecol Oncol 2018
15
33

Do Breast Cancer Patients Tested in the Oncology Care Setting Share BRCA Mutation Results with Family Members and Health Care Providers?
Susan T Vadaparampil, Teri Malo, Cara de la Cruz, Juliette Christie. J Cancer Epidemiol 2012
10
33

A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
Erica M Bednar, Holly D Oakley, Charlotte C Sun, Catherine C Burke, Mark F Munsell, Shannon N Westin, Karen H Lu. Gynecol Oncol 2017
26
33


Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Mary B Daly, Robert Pilarski, Jennifer E Axilbund, Michael Berry, Saundra S Buys, Beth Crawford, Meagan Farmer, Susan Friedman, Judy E Garber, Seema Khan,[...]. J Natl Compr Canc Netw 2016
111
33

Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis.
Casey L Swanson, Amanika Kumar, Joy M Maharaj, Jennifer L Kemppainen, Brittany C Thomas, Megan R Weinhold, Kristine M Slaby, Kristin C Mara, Myra J Wick, Jamie N Bakkum-Gamez. Gynecol Oncol 2018
13
33


Report from the National Society of Genetic Counselors service delivery model task force: a proposal to define models, components, and modes of referral.
Stephanie A Cohen, Shanna L Gustafson, Monica L Marvin, Bronson D Riley, Wendy R Uhlmann, S Bonnie Liebers, Julie A Rousseau. J Genet Couns 2012
45
33

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
Leslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, John P Diaz, Adam Buchanan, Catherine T Witkop, C Bethan Powell, Ellen Blair Smith, Mark E Robson, Jeff Boyd,[...]. Gynecol Oncol 2017
52
33

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
107
33

Information Mismatch: Cancer Risk Counseling with Diverse Underserved Patients.
Galen Joseph, Rena J Pasick, Dean Schillinger, Judith Luce, Claudia Guerra, Janice Ka Yan Cheng. J Genet Couns 2017
46
33

Genetic counseling gone awry: miscommunication between prenatal genetic service providers and Mexican-origin clients.
C H Browner, H Mabel Preloran, Maria Christina Casado, Harold N Bass, Ann P Walker. Soc Sci Med 2003
61
33

Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer.
Jeanna M McCuaig, Susan Randall Armel, Melanie Care, Alexandra Volenik, Raymond H Kim, Kelly A Metcalfe. Cancers (Basel) 2018
29
33


Satisfaction with physician recommendation for and information about genetic counseling among breast cancer patients.
Susan T Vadaparampil, Gwendolyn P Quinn, Ji-Hyun Lee, Teri Malo, Xiuhua Zhao, Cheryl Miree, Jennifer Brzosowicz. Breast J 2011
8
33

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
44
33

Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
Susan T Vadaparampil, Gwendolyn P Quinn, Cheryl A Miree, Jennifer Brzosowicz, Bradford Carter, Christine Laronga. Ann Surg Oncol 2009
25
33

Financial Toxicity of Cancer Care: It's Time to Intervene.
S Yousuf Zafar. J Natl Cancer Inst 2015
210
33


Qualitative research methods: when to use them and how to judge them.
K Hammarberg, M Kirkman, S de Lacey. Hum Reprod 2016
110
33


Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda.
Jada G Hamilton, Ekland Abdiwahab, Heather M Edwards, Min-Lin Fang, Andrew Jdayani, Erica S Breslau. J Gen Intern Med 2017
45
33

Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer.
R Wendel Naumann, Jacob C Morris, David L Tait, Robert V Higgins, Erin K Crane, Lane K Drury, Lisa Amacker-North, Megan Templin, Jubilee Brown. Gynecol Oncol 2018
10
33

Skin cancer concerns and genetic risk information-seeking in primary care.
J Hay, K A Kaphingst, R Baser, Y Li, S Hensley-Alford, C M McBride. Public Health Genomics 2012
21
33

A survey of UK public interest in internet-based personal genome testing.
Lynn F Cherkas, Juliette M Harris, Elana Levinson, Tim D Spector, Barbara Prainsack. PLoS One 2010
75
33

Preferences of women with epithelial ovarian cancer for aspects of genetic testing.
Brittany A Davidson, Jessie Ehrisman, Shelby D Reed, Jui-Chen Yang, Adam Buchanan, Laura J Havrilesky. Gynecol Oncol Res Pract 2019
6
33

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
296
33

Gene deletion of glutathione S-transferase M1 and T1 and risk factors of hepatocellular carcinoma in Egyptian patients.
Elhamy Abd El-Moneim, Fatma A Younis, Naglaa Allam, Khaled Gameel, Maher Osman. Egypt J Immunol 2008
13
33

The relationship between telomere length and clinicopathologic characteristics in colorectal cancers among Tunisian patients.
Raja Mzahma, Maher Kharrat, Fadhel Fetiriche, Bouasker, Mounir Ben Moussa, Zoubeir Ben Safta, Chadli Dziri, AbdelJelil Zaouche, Habiba Chaabouni-Bouhamed. Tumour Biol 2015
3
33

Leptin is overexpressed in the tumor microenvironment of obese patients with estrogen receptor positive breast cancer.
Mohamed Hosney, Salwa Sabet, Mohamed El-Shinawi, Khadiga M Gaafar, Mona M Mohamed. Exp Ther Med 2017
19
33

Genomic instability in complicated and uncomplicated Egyptian schistosomiasis haematobium patients.
Amany A Abd El-Aal, Ibrahim R Bayoumy, Maha M A Basyoni, Asmaa A Abd El-Aal, Ashraf M Emran, Magda S Abd El-Tawab, Manal A Badawi, Rabab M Zalat, Tarek M Diab. Mol Cytogenet 2015
8
33

Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.
Menha Swellam, Manal Ismail, Sanaa Eissa, Mohamed Hamdy, Nadia Mokhtar. IUBMB Life 2004
10
33

Tumor necrosis factor alpha-308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt.
Azza Ibrahim, Hala Abdel Rahman, Mervat Khorshied, Rania Sami, Nelly Nasr, Ola Khorshid. Leuk Res 2012
15
33

BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors.
Khalid Dafaallah Awadelkarim, Gitana Aceto, Serena Veschi, Ahmed Elhaj, Annalisa Morgano, Ahmed Abdalla Mohamedani, Elgaylani Abdalla Eltayeb, Dafaallah Abuidris, Mario Di Gioacchino, Pasquale Battista,[...]. Breast Cancer Res Treat 2007
32
33

Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus.
R S Mboumba Bouassa, T Prazuck, T Lethu, J F Meye, L BĂ©lec. Med Sante Trop 2017
9
33

The single nucleotide polymorphism +936 C/T VEGF is associated with human epidermal growth factor receptor 2 expression in Moroccan breast cancer women.
Jalila Rahoui, Yassir Sbitti, Nadia Touil, Abdelilah Laraqui, Azeddine Ibrahimi, Brahim Rhrab, Abderrahman Al Bouzidi, Driss Moussaoui Rahali, Mohamed Dehayni, Mohamed Ichou,[...]. Med Oncol 2014
8
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.